معلومات السلامة في نشرات الأدوية

تصفية

Scientific Name	Trade Name	Updated Section	Month
Cabazitaxel	Jevtana	4.8 Undesirable effects	Mar,2023
Cephalexin	Keflex	4.4 Special Warnings and Special Precautions for Use	Mar,2023
ASCORBIC ACID,SODIUM ASCORBATE,SODIUM SULFATE,MACROGOL ,POTASSIUM CHLORIDE,SODIUM CHLORIDE	Moviprep	4.4 Special warnings and precautions for use	Mar, 2026
Marstacimab	HYMPAVZI	4.8. Undesirable effects	Jun, 2026
Valproate Sodium	Epilim Chrono	4.2 Posology and Method of Administration 6.6 Special Precautions for Disposal and Handling	Jun, 2026
OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE	SEVIKAR HCT	4.4 Special warnings and precautions for use 4.8. Undesirable effects	Jun, 2026
METHYLPHENIDATE	Quillivant XR	4.2 Posology and method of administration	Jun, 2026
Liraglutide	Victoza	4.8. Undesirable effects	Jun, 2024
Infliximab	Renflexis	4.8. Undesirable effects	July, 2026
IPTACOPAN	Fabhalta	4.5 Interaction with other medicinal products and other forms of interaction	July, 2026